# Delivery Order #SPE2DR26FCKYF

DMS Pharmaceutical Group Supplies Midazolam for Federal Healthcare Needs

**Buyer:** Defense Logistics Agency

**Award Amount:** $27.90
**Ceiling:** $27.90

**Awarded:** June 24, 2026
**Period of Performance:** Jun 24, 2026 - Jun 25, 2026

**Identifier:** SPE2DR26FCKYF
**NAICS:** 325411

This is a delivery order under DMS Pharmaceutical Group Inc.’s parent indefinite-delivery contract, a flexible vehicle for ordering pharmaceutical products for European operations. The order covers midazolam hydrochloride injection, specified as 5 mg/mL vials, for delivery to Park Ridge, Illinois. DMS Pharmaceutical Group Inc. supplies pharmaceutical products and services; no parent company beyond the named recipient is identified in the available data. The medication supports healthcare operations by providing an injectable medicine used in clinical care. The order is associated with the parent contract’s long-term period of performance, while this individual order has a very short performance window. The available record does not identify whether the order was competed or sole-source, provide a solicitation or acquisition program, or list subcontractors or earlier related orders. No transaction history is provided. Specific dates and dollar amounts are omitted as requested.

### Description

4572443234!MIDAZOLAM HCL 5 MG/ML VIALML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DR26FCKYF_9700_SPE2DR25D9966_9700)
